Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Online |
| Kieli: | englanti |
| Julkaistu: |
Frontiers Media SA
2021
|
| Aiheet: | |
| Linkit: | 25629 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1869531199135809536 |
|---|---|
| author | Carlos P. Taborda Joshua D. Nosanchuk |
| author_browse | Carlos P. Taborda Joshua D. Nosanchuk |
| author_facet | Carlos P. Taborda Joshua D. Nosanchuk |
| author_sort | Carlos P. Taborda |
| collection | Directory of Open Access Books |
| description | Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi. |
| format | Online |
| id | doab-20.500.12854ir-61823 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-618232024-04-05T17:31:07Z Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier Carlos P. Taborda Joshua D. Nosanchuk QR1-502 Q1-390 antifugal drugs vaccine peptide antibody virulence fungi immunotherapy humanized antibody mycosis cell biology thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi. 2021-02-12T07:18:22Z 2021-02-12T07:18:22Z 2018-02-27 16:16:45 2017 book 25629 16648714 9782889453276 https://directory.doabooks.org/handle/20.500.12854/61823 eng Frontiers Research Topics image/jpeg Attribution 4.0 International https://www.frontiersin.org/books/Vaccines_Immunotherapy_and_New_Antifungal_Therapy_Against_Fungi_Updates_in_the_New_Frontier/1377 https://www.frontiersin.org/research-topics/4726/vaccines-immunotherapy-and-new-antifungal-therapy-against-fungi-updates-in-the-new-frontier Frontiers Media SA 10.3389/978-2-88945-327-6 10.3389/978-2-88945-327-6 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889453276 183 open access |
| spellingShingle | QR1-502 Q1-390 antifugal drugs vaccine peptide antibody virulence fungi immunotherapy humanized antibody mycosis cell biology thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) Carlos P. Taborda Joshua D. Nosanchuk Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title | Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title_full | Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title_fullStr | Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title_full_unstemmed | Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title_short | Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| title_sort | vaccines immunotherapy and new antifungal therapy against fungi updates in the new frontier |
| topic | QR1-502 Q1-390 antifugal drugs vaccine peptide antibody virulence fungi immunotherapy humanized antibody mycosis cell biology thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) |
| topic_facet | QR1-502 Q1-390 antifugal drugs vaccine peptide antibody virulence fungi immunotherapy humanized antibody mycosis cell biology thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSG Microbiology (non-medical) |
| url | 25629 |
| work_keys_str_mv | AT carlosptaborda vaccinesimmunotherapyandnewantifungaltherapyagainstfungiupdatesinthenewfrontier AT joshuadnosanchuk vaccinesimmunotherapyandnewantifungaltherapyagainstfungiupdatesinthenewfrontier |